Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation.

Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation (2010) 1.10

Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection. Am J Transplant (2012) 1.06

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement. Am J Transplant (2013) 0.96

Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I. J Am Soc Nephrol (2014) 0.77

Living donor renal transplantation in patients with antiphospholipid syndrome: A case report. Medicine (Baltimore) (2016) 0.75

Significance of anticardiolipin antibodies on short- and long-term allograft survival and function following kidney transplantation. Am J Transplant (2004) 0.75

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Strategies to improve long-term outcomes after renal transplantation. N Engl J Med (2002) 6.76

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48

Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis (2012) 2.48

Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol (2011) 2.17

Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int (2004) 2.01

Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98

Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol (2009) 1.88

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol (2010) 1.82

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75

Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72

Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin Infect Dis (2008) 1.72

Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol (2008) 1.70

Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65

Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg (2006) 1.53

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52

Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46

Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant (2007) 1.43

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41

Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol (2002) 1.39

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation (2007) 1.24

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation (2004) 1.22

Mortality among living kidney donors and comparison populations. N Engl J Med (2010) 1.20

A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis (2011) 1.17

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17

Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation (2008) 1.16

Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant (2005) 1.13

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol (2009) 1.09

Sensitization after kidney transplantation. Clin J Am Soc Nephrol (2006) 1.09

Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med (2007) 1.04

CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. Ther Drug Monit (2008) 1.04

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03

Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg (2007) 1.03

Arabidopsis monothiol glutaredoxin, AtGRXS17, is critical for temperature-dependent postembryonic growth and development via modulating auxin response. J Biol Chem (2011) 1.00

Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients. Pharmacogenet Genomics (2008) 0.99

Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action. Int Immunopharmacol (2009) 0.98

Retracted Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol (2009) 0.97

Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol (2004) 0.97

Humoral rejection of organ allografts. Am J Transplant (2005) 0.94

Factors in career choice among US nephrologists. Clin J Am Soc Nephrol (2012) 0.94

Update in renal transplantation. Arch Intern Med (2004) 0.94

Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation (2006) 0.94

Effectiveness of transforaminal epidural steroid injections in patients with degenerative lumbar scoliotic stenosis and radiculopathy. Pain Physician (2004) 0.94

Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation (2007) 0.92

Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. Drugs (2008) 0.92

Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol (2013) 0.91

Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol (2008) 0.91

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91

Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health (2010) 0.91

Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant (2004) 0.91

2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation (2005) 0.90

Ectopic expression of Arabidopsis glutaredoxin AtGRXS17 enhances thermotolerance in tomato. Plant Biotechnol J (2012) 0.90

Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. Antivir Ther (2008) 0.89

Effect of perioperative blood transfusions on long term graft outcomes in renal transplant patients. Clin Nephrol (2012) 0.88

Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation (2010) 0.87

Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant (2011) 0.87

New treatments for acute humoral rejection of kidney allografts. Expert Opin Investig Drugs (2007) 0.87

Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet A (2011) 0.87

Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation. Transpl Immunol (2008) 0.86

Teres minor denervation on routine magnetic resonance imaging of the shoulder. Skeletal Radiol (2004) 0.86

Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease. Clin Transplant (2009) 0.86

Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol (2004) 0.86

Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int (2007) 0.86

Development of an outpatient native kidney biopsy service in low-risk patients: a multidisciplinary approach. Am J Nephrol (2012) 0.85

From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int (2007) 0.85

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. Transpl Immunol (2012) 0.84

Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int (2009) 0.84

Mycosis fungoides and sezary syndrome: an update. Curr Oncol Rep (2006) 0.84

Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients. BMC Infect Dis (2010) 0.84

Paroxysmal hypertension in a 48-year-old woman. Kidney Int (2008) 0.84

Post-menopausal hormone use and albuminuria. Nephrol Dial Transplant (2009) 0.83

Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats. Eur J Cardiothorac Surg (2006) 0.83

Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection. J Am Soc Nephrol (2002) 0.83

Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation. Expert Rev Anti Infect Ther (2011) 0.83

Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements. Clin Pharmacokinet (2009) 0.83

Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland. J Heart Lung Transplant (2011) 0.81

Cytomegalovirus infection and new-onset post-transplant diabetes mellitus. Clin Transplant (2008) 0.81

Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients. Clin Immunol (2010) 0.81

Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant (2006) 0.81

Accurate, fast, and convenient measurement of glomerular filtration rate in potential renal transplant donors. Transplantation (2010) 0.81

Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients. Clin J Am Soc Nephrol (2011) 0.80

Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland. Nephrology (Carlton) (2013) 0.80

Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients. Transplantation (2011) 0.80

Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells. Liver Transpl (2010) 0.79

Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation. Swiss Med Wkly (2006) 0.79

Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone. Clin Transplant (2003) 0.79